ProNAi Therapeutics (DNAI) Posts Wider-than-Expected Q3 Loss

ProNAi Therapeutics (NASDAQ: DNAI) reported Q3 EPS of ($11.03), $10.55 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• X-Energy, Inc. (XE) Reports Q2 Loss of $0.15
• Dillard's (DDS) Tops Q2 EPS by $1.93, Misses on Revenue